Patents by Inventor Yanick Bertrand

Yanick Bertrand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110243952
    Abstract: The invention relates to novel regulators of plasminogen activation and their use for regulating cell migration, plasminolysis, angiogenesis, fibrinolysis, for treating cancer and thrombo-embolic diseases such as heart stroke. Furthermore, the present invention relates to novel pharmaceutical compositions form regulating cell migration, plasminolysis, angiogenesis and for treating cancer. In particular, the present invention relates to a method of regulating the activation of plasminogen comprising contacting a solution of pro-urokinase (uPA) or tissue plasminogen activator (tPA) and plasminogen with melanotransferrin (p97) for a time sufficient to effect regulation thereof.
    Type: Application
    Filed: March 28, 2011
    Publication date: October 6, 2011
    Applicant: TRANSFERT PLUS
    Inventors: Richard Béliveau, Michel Demeule, Yanick Bertrand, Jonathan Michaud-Levesque, Yannève Rolland, Julie Jodoin
  • Patent number: 7919103
    Abstract: The invention relates to novel regulators of plasminogen activation and their use for regulating cell migration, plasminolysis, angiogenesis, fibrinolysis, for treating cancer and thrombo-embolic diseases such as heart stroke. Furthermore, the present invention relates to novel pharmaceutical compositions form regulating cell migration, plasminolysis, angiogenesis and for treating cancer. In particular, the present invention relates to a method of regulating the activation of plasminogen comprising contacting a solution of pro-urokinase (uPA) or tissue plasminogen activator (tPA) and plasminogen with melanotransferrin (p97) for a time sufficient to effect regulation thereof.
    Type: Grant
    Filed: May 7, 2004
    Date of Patent: April 5, 2011
    Assignee: Transfert Plus
    Inventors: Richard Béliveau, Michel Demeule, Yanick Bertrand, Jonathan Michaud-Levesque, Yannève Rolland, Julie Jodoin
  • Publication number: 20070053894
    Abstract: The invention relates to novel regulators of plasminogen activation and their use for regulating cell migration, plasminolysis, angiogenesis, fibrinolysis, for treating cancer and thrombo-embolic diseases such as heart stroke. Furthermore, the present invention relates to novel pharmaceutical compositions form regulating cell migration, plasminolysis, angiogenesis and for treating cancer. In particular, the present invention relates to a method of regulating the activation of plasminogen comprising contacting a solution of pro-urokinase (uPA) or tissue plasminogen activator (tPA) and plasminogen with melanotransferrin (p97) for a time sufficient to effect regulation thereof.
    Type: Application
    Filed: May 7, 2004
    Publication date: March 8, 2007
    Applicant: TRANSFERT PLUS
    Inventors: Richard Beliveau, Michel Demeule, Yanick Bertrand, Jonathan Michaud-Levesque, Yanneve Rolland, Julie Jodoin
  • Publication number: 20060143037
    Abstract: The system for taking over and operating services and installations at a site comprise portable means for collecting data at the site and a central unit comprising a module for analyzing the services and technical installations of the site, a computer-assisted maintenance manager module, and a module for following up and optimizing operation and maintenance of the site, said module analyzing maintenance and breakdowns in order to modify the classification of the corresponding equipment in the analysis module and in order to modify the corresponding maintenance schedules in the maintenance manager module.
    Type: Application
    Filed: June 16, 2005
    Publication date: June 29, 2006
    Inventors: Serge Artiguenave, Yanick Bertrand, Luc Chilou, Philippe Manguine, Francois Vidal